Letters

Lack of funding will inhibit evidence based commissioning of cancer treatments

BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7226.54 (Published 01 January 2000) Cite this as: BMJ 2000;320:54
  1. June So, chief pharmacist,
  2. J Howard Scarffe, professor of medical oncology,
  3. Elizabeth Rous, consultant in public health medicine,
  4. Robbie Foy, clinical research fellow (R.Foy@ed.ac.uk)
  1. Christie Hospital NHS Trust, Manchester M20 4BX
  2. Manchester Health Authority, Gateway House, Manchester M60 7LP
  3. Scottish Programme for Clinical Effectiveness in Reproductive Health, Department of Obstetrics and Gynaecology, University of Edinburgh, Edinburgh EH3 9AW

    EDITOR—We welcome the appointment of a cancer tsar to improve the treatment of patients with cancer in the NHS.1 However, more resources and greater transparency in their allocation will be necessary to improve survival rates in the United Kingdom in relation to its …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe